111P - Pilot Study on the Feasibility, Safety and Immunogenicity of a Personalized Neoantigen-Targeted Immunotherapy (NeoPepVac) in Combination with Anti-PD-1 or Anti-PD-L1 in Advanced Solid Tumors
| Autor: | Moerk, S.K., Donia, M., Kringelum, J.V., Bogenrieder, T., Rønø, B., Sorensen, A.B., Draghi, A., Bol, K.F., Petersen, N.V., Kadivar, M., Hernandez, S.S., Hadrup, S. Reker, Andreasen, L.V., Christensen, D., Andersen, P.L., Svane, I.M. |
|---|---|
| Zdroj: | In Annals of Oncology December 2019 30 Supplement 11:xi41-xi41 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|